Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Karola Jering, M.D.

Concepts (129)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure242023109001.640 Why?
Ramipril82023950.880 Why?
Myocardial Infarction122024117270.880 Why?
Angiotensin Receptor Antagonists820239240.660 Why?
Stroke Volume19202350070.650 Why?
Angiotensin-Converting Enzyme Inhibitors6202215180.550 Why?
Mercury Poisoning12015330.520 Why?
Parenteral Nutrition Solutions12015270.520 Why?
Biphenyl Compounds720239130.500 Why?
Drug Combinations8202319590.480 Why?
Tetrazoles820238350.480 Why?
Delivery, Obstetric120219060.470 Why?
Mercury120152850.430 Why?
Defibrillators, Implantable1202114400.410 Why?
Organ Transplantation1202111390.390 Why?
Pulmonary Edema220244140.370 Why?
Parenteral Nutrition120156500.370 Why?
Ventricular Function, Left8202336700.360 Why?
Pregnancy Complications, Infectious1202120260.340 Why?
Ventricular Dysfunction, Left4202420730.340 Why?
Critical Care1202126470.320 Why?
Neprilysin420224390.300 Why?
Aortic Valve Stenosis1202019650.300 Why?
Clinical Trials as Topic1202279130.280 Why?
Natriuretic Peptide, Brain2202315730.240 Why?
Prognosis72023290630.230 Why?
Prospective Studies102023532880.220 Why?
Hyperkalemia120232180.200 Why?
Hospitalization62023102620.190 Why?
Benzhydryl Compounds220238450.190 Why?
Hospital Mortality4202153170.190 Why?
Hypotension220238840.180 Why?
Pulmonary Embolism2202223760.180 Why?
Peptide Fragments2202350970.170 Why?
Receptors, Angiotensin320221420.160 Why?
Humans3520247443430.150 Why?
Troponin I120216190.140 Why?
Troponin T120217540.140 Why?
International Classification of Diseases120218670.130 Why?
Renin-Angiotensin System120207590.130 Why?
Atrial Fibrillation2202350340.120 Why?
Inhibitor of Differentiation Protein 212014320.120 Why?
Anemia1202315060.120 Why?
Proto-Oncogene Proteins c-sis120142510.110 Why?
Comorbidity32023103880.110 Why?
Guideline Adherence1202222660.100 Why?
Antihypertensive Agents1202120460.100 Why?
Angiotensins220221510.100 Why?
Cardiomyopathies1202319120.100 Why?
Female1420233801940.100 Why?
Pregnancy Outcome1202127950.090 Why?
Stroke2202399810.090 Why?
Inpatients1202225180.090 Why?
Oligodendroglia120145170.090 Why?
Venous Thromboembolism1202216710.090 Why?
Glucosides220234510.090 Why?
Renal Insufficiency, Chronic1202322080.080 Why?
Calcium1202257560.080 Why?
Pulmonary Disease, Chronic Obstructive1202330470.080 Why?
Heart Diseases1202127880.080 Why?
Neural Stem Cells120148510.070 Why?
Infant, Premature1201520440.070 Why?
Kidney1202071860.060 Why?
Diabetes Mellitus1202357510.060 Why?
Registries1202080890.060 Why?
Kansas12023390.060 Why?
Europe, Eastern12023750.060 Why?
Severity of Illness Index12021155400.060 Why?
Thrombolytic Therapy2202221610.060 Why?
Aged720231632800.050 Why?
Male1020233501180.050 Why?
Furosemide120221670.050 Why?
Sodium Potassium Chloride Symporter Inhibitors120221350.050 Why?
Electrolytes120222820.050 Why?
Pulmonary Circulation120247390.050 Why?
Risk Factors32022722900.050 Why?
Pandemics1202183880.050 Why?
Diuretics120225920.040 Why?
Self Efficacy120236160.040 Why?
Pregnancy12021291440.040 Why?
Middle Aged620232133830.040 Why?
Proportional Hazards Models22023123540.040 Why?
Hypertrophy, Left Ventricular120228590.040 Why?
Europe1202333390.030 Why?
United States22021698720.030 Why?
Infant, Newborn12015256250.030 Why?
Treatment Outcome12020631140.030 Why?
Point-of-Care Systems1202211770.030 Why?
Infant12015351360.030 Why?
Sex Characteristics1202325850.030 Why?
Renal Dialysis1202217860.030 Why?
Quality of Life22023128040.030 Why?
Up-Regulation1202142170.030 Why?
Acute Disease1202271490.030 Why?
Receptor, Platelet-Derived Growth Factor alpha120143790.030 Why?
Patient Care Team1202325310.020 Why?
Hemorrhage1202234610.020 Why?
Adult220212140550.020 Why?
Health Status1202340340.020 Why?
Echocardiography1202251020.020 Why?
Anticoagulants1202345990.020 Why?
Pilot Projects1202183240.020 Why?
Basic Helix-Loop-Helix Transcription Factors1201411140.020 Why?
Double-Blind Method12021120260.020 Why?
Randomized Controlled Trials as Topic1202399590.020 Why?
Aged, 80 and over22023577760.020 Why?
Predictive Value of Tests12021150760.020 Why?
Lung1202398560.020 Why?
Emergency Service, Hospital1202276590.010 Why?
Cell Cycle Proteins1201434620.010 Why?
Promoter Regions, Genetic1201458670.010 Why?
Tumor Microenvironment1201435860.010 Why?
Obesity12023127450.010 Why?
Nerve Tissue Proteins1201444620.010 Why?
Gene Expression1201477990.010 Why?
Risk Assessment12021233380.010 Why?
Time Factors12021400750.010 Why?
Glioma1201434010.010 Why?
Mice, Knockout12014145570.010 Why?
Cell Proliferation12014104810.010 Why?
Cells, Cultured12014192290.010 Why?
Gene Expression Regulation, Neoplastic1201484280.010 Why?
Cell Differentiation12014114830.010 Why?
Cardiovascular Diseases12021151650.010 Why?
Mice, Inbred C57BL12014218270.010 Why?
Young Adult12021564300.010 Why?
Brain Neoplasms1201488630.010 Why?
Mice12014811830.000 Why?
Animals120141687570.000 Why?
Jering's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.